Skip Navigation

MPS-1 Data Details

MPS-1 Increase the proportion of medical-surgical hospitals that report adverse drug events

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Survey of Pharmacy Practice in Hospital Care Settings; American Society of Health-System Pharmacists (ASHP)
Changed Since the Healthy People 2020 Launch
Yes
Measure
percent 
Baseline (Year)
60.7 (2009)
Target
66.8
Target-Setting Method
10 percent improvement
Numerator

Number of general and children’s medical-surgical hospitals that report adverse drug events externally (e.g. to FDA, Medwatch, Institute for Safe Medication Practices, manufacturer)

Denominator

Number of general and children’s medical-surgical hospitals

Questions Used to Obtain the National Baseline Data

From the 2009 National Survey of Pharmacy Practice in Hospital Care Settings:

[NUMERATOR:]

Does your hospital report adverse drug events externally (e.g., FDA, Medwatch, ISMP, manufacturer)?

  1. Yes
  2. No
Data Collection Frequency
Periodic
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
Methodology Notes

For this objective, an adverse drug event is an injury resulting from the use of, or not using, a needed medication. Adverse drug events include both adverse drug reactions and medication errors, including both errors of commission and omission, that result in adverse clinical outcomes.

General and children’s medical-surgical hospitals were stratified by the size of the hospital (number of staffed beds), then sampled randomly. The sample focused on inpatient settings, rather than ambulatory settings. Specialty, federal, and VA hospitals were excluded from the sampling frame. The pharmacy directors of sampled hospitals were surveyed by mail.

Hospitals were counted as reporting adverse drug events externally if they reported to FDA, Medwatch, Institute for Safe Medication Practices, or the manufacturer.

Caveats and Limitations
40% response to paper survey.

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

The objective and baseline statements were revised to more accurately reflect the measure. The original objective statement was "Increase the proportion of health care organizations that are monitoring and analyzing adverse events associated with medical therapies within their systems." The revised objective statement is "Increase the proportion of medical-surgical hospitals that report adverse drug events." The original baseline statement was "60.7 percent of of general and children’s hospital systems reported adverse drug events externally in 2009." The revised objective statement is "60.7 percent of medical-surgical hospitals reported adverse drug events in 2009." The data source, data, target, and target setting method were not revised.

References

Additional resources about the objective.

  1. Farley DO, Haviland A, Champagne S, et. Al Berdahl TA. Adverse-Event-Reporting Practices by U.S. Hospitals: Results of a National Survey. Qual Saf Health Care 2008, Dec; 17(6): 416-423.
  2. Pedersen, CA, Schneider, PJ, Scheckelhoff, DJ. ASHP National Survey of Pharmacy Practice in Hospital Settings: Monitoring and Patient Education-2006. Am J Health-Syst Pharm 2007 Mar; 64.
  3. Pedersen, CA, Schneider, PJ, Scheckelhoff, DJ. ASHP National Survey of Pharmacy Practice in Hospital Settings: Monitoring and Patient Education-2012. Am J Health-Syst Pharm 2013 May; 70.